These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12847570)

  • 1. Vaccination for the prevention and treatment of Alzheimer's disease.
    Solomon B; Frenkel D
    Drugs Today (Barc); 2000 Sep; 36(9):655-63. PubMed ID: 12847570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration.
    Frenkel D; Katz O; Solomon B
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11455-9. PubMed ID: 11027345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards Alzheimer's beta-amyloid vaccination.
    Frenkel D; Solomon B
    Biologicals; 2001; 29(3-4):243-7. PubMed ID: 11851323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of auto-antibodies towards Alzheimer's disease vaccination.
    Frenkel D; Kariv N; Solomon B
    Vaccine; 2001 Mar; 19(17-19):2615-9. PubMed ID: 11257400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapeutic strategies for prevention and treatment of Alzheimer's disease.
    Solomon B
    DNA Cell Biol; 2001 Nov; 20(11):697-703. PubMed ID: 11788047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination.
    Solomon B
    Vaccine; 2005 Mar; 23(17-18):2327-30. PubMed ID: 15755621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and brain delivery of anti-aggregating antibodies against beta-amyloid plaques using phage display technology.
    Solomon B; Frenkel D
    J Neural Transm Suppl; 2002; (62):321-5. PubMed ID: 12456075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filamentous bacteriophage as a novel therapeutic tool for Alzheimer's disease treatment.
    Solomon B
    J Alzheimers Dis; 2008 Oct; 15(2):193-8. PubMed ID: 18953108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active immunization against Alzheimer's beta-amyloid peptide using phage display technology.
    Solomon B
    Vaccine; 2007 Apr; 25(16):3053-6. PubMed ID: 17287054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal EFRH sequence of Alzheimer's beta-amyloid peptide represents the epitope of its anti-aggregating antibodies.
    Frenkel D; Balass M; Solomon B
    J Neuroimmunol; 1998 Aug; 88(1-2):85-90. PubMed ID: 9688328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization.
    Frenkel D; Dewachter I; Van Leuven F; Solomon B
    Vaccine; 2003 Mar; 21(11-12):1060-5. PubMed ID: 12559780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials.
    Lavie V; Becker M; Cohen-Kupiec R; Yacoby I; Koppel R; Wedenig M; Hutter-Paier B; Solomon B
    J Mol Neurosci; 2004; 24(1):105-13. PubMed ID: 15314258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of anti-beta-amyloid antibodies via phage display technology.
    Frenkel D; Dori M; Solomon B
    Vaccine; 2004 Jun; 22(19):2505-8. PubMed ID: 15193416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease and immunotherapy.
    Solomon B
    Curr Alzheimer Res; 2004 Aug; 1(3):149-63. PubMed ID: 15975063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High affinity binding of monoclonal antibodies to the sequential epitope EFRH of beta-amyloid peptide is essential for modulation of fibrillar aggregation.
    Frenkel D; Balass M; Katchalski-Katzir E; Solomon B
    J Neuroimmunol; 1999 Mar; 95(1-2):136-42. PubMed ID: 10229123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Molecules in Alzheimer's Disease: Therapeutic Antibodies.
    Solomon B
    Drug News Perspect; 2002 Sep; 15(7):410-416. PubMed ID: 12677176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.
    Schiltz JG; Salzer U; Mohajeri MH; Franke D; Heinrich J; Pavlovic J; Wollmer MA; Nitsch RM; Moelling K
    J Mol Med (Berl); 2004 Oct; 82(10):706-14. PubMed ID: 15241501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-amyloidbased immunotherapy as a treatment of Alzheimers disease.
    Solomon B
    Drugs Today (Barc); 2007 May; 43(5):333-42. PubMed ID: 17724499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
    Geylis V; Steinitz M
    Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.